Shiga toxin glycosphingolipid receptors of Vero-B4 kidney epithelial cells and their membrane microdomain lipid environment

Journal of Lipid Research

Volumn 56, Issue 12, 2015, Pages 2322-2336

  Steil, Daniel ^a   Schepers, Catherine Louise ^a   Pohlentz, Gottfried ^a   Legros, Nadine ^a   Runde, Jana ^a   Humpf, Hans Ulrich ^a   Karch, Helge ^a   Müthing, Johannes ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Enterohemorrhagic escherichia coli; Globo series; Globopentaosylceramide; Glycolipids; Lysophospholipids; Mass spectrometry; Microdomains; Phospholipids; Shiga toxin producing escherichia coli; Sphingolipids

Indexed keywords

CHOLESTEROL; GLOBOTETRAOSYLCERAMIDE; GLOBOTRIAOSYLCERAMIDE; RECEPTOR; SHIGA TOXIN; SHIGA TOXIN 1A; SHIGA TOXIN 2A; SHIGA TOXIN 2E; SHIGA TOXIN GLYCOSPHINGOLIPID RECEPTOR; SPHINGOLIPID; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; CERAMIDE TRIHEXOSIDE; FORSSMAN ANTIGEN; GLOBOSIDE; GLYCOSPHINGOLIPID; SHIGELLA TOXIN RECEPTOR;

ANIMAL CELL; ARTICLE; CELL VIABILITY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CYTOTOXICITY TEST; DENSITY GRADIENT; INTERNALIZATION; LIPID MEMBRANE; LIPID RAFT; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; VERO CELL LINE; ANIMAL; CELL MEMBRANE; CHLOROCEBUS AETHIOPS; CYTOLOGY; EPITHELIUM CELL; KIDNEY; METABOLISM;

ANIMALS; CERCOPITHECUS AETHIOPS; EPITHELIAL CELLS; GLOBOSIDES; GLYCOSPHINGOLIPIDS; KIDNEY; MEMBRANE MICRODOMAINS; RECEPTORS, CELL SURFACE; SHIGA TOXIN; TRIHEXOSYLCERAMIDES; VERO CELLS;

EID: 84949023966     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M063040     Document Type: Article

References (102)

1. Ammermann , N. C. , M. Beier-Sexton , and A. F. Azad . 2008 . Growth and maintenance of Vero cell lines. Curr. Protoc. Microbiol. Appendix 4 : Appendix 4E .
2. Nicolson , C. , D. Major , J. M. Wood , and J. S. Robertson . 2005 . Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system. Vaccine . 23 : 2943 - 2952 .
3. Barrett , P. N. , D. Portsmouth , and H. J. Ehrlich . 2010 . Developing cell culture-derived pandemic vaccines. Curr. Opin. Mol. Ther. 12 : 21 - 30 .
4. Feng , S. Z. , P. R. Jiao , W. B. Qi , H. Y. Fan , and M. Liao . 2011 . Development and strategies of cell-culture technology for influenza vaccine. Appl. Microbiol. Biotechnol. 89 : 893 - 902 .
5. Montomoli , E. , B. Khadang , S. Piccirella , C. Trombetta , E. Mennitto , I. Manini , V. Stanzani , and G. Lapini . 2012 . Cell culture-derived influenza vaccines from Vero cells: a new horizon for vaccine production. Expert Rev. Vaccines . 11 : 587 - 594 .
6. Ohkusa , T. , I. Okayasu , T. Ogihara , K. Morita , M. Ogawa , and N. Sato . 2003 . Induction of experimental ulcerative colitis by Fusobacterium varium isolated from colonic mucosa of patients with ulcerative colitis. Gut . 52 : 79 - 83 .
7. Dingle , T. , S. Wee , G. L. Mulvey , A. Greco , E. N. Kitova , J. Sun , S. Lin , J. S. Klassen , M. M. Palcic , K. K. S. Ng , et al . 2008 . Functional properties of the carboxy-terminal host cell-binding domains of the two toxins, TcdA and TcdB, expressed by Clostridium difficile. Glycobiology . 18 : 698 - 706 .
8. Pellarín , M. G. , C. Albrecht , M. J. Rojas , J. J. Aguilar , B. S. Konigheim , M. G. Paraje , I. Albesa , and A. J. Eraso . 2013 . Inhibition of cytotoxicity of Shiga toxin of Escherichia coli O157:H7 on Vero cells by Prosopis alba Griseb (Fabaceae) and Ziziphus mistol Griseb (Rhamnaceae) extracts. J. Food Prot. 76 : 1733 - 1739 .
9. Kakisu , E. , A. G. Abraham , C. T. Farinati , C. Ibarra , and G. L. de Antonia . 2013 . Lactobacillus plantarum isolated fromk kefir protects Vero cells from cytotoxicity by type-II Shiga toxin from Escherichia coli O157:H7. J. Dairy Res. 80 : 64 - 71 .
10. Funk , J. , N. Biber , M. Schneider , E. Hauser , S. Enzenmüller , C. Förtsch , H. Barth , and H. Schmidt . 2015 . Cytotoxic and apoptotic effects of recombinant subtilase cytotoxin variants of Shiga toxinproducing Escherichia coli. Infect. Immun. 83 : 2338 - 2349 .
11. Konowalchuk , J. , J. I. Speirs , and S. Stavric . 1977 . Vero response to a cytotoxin of Escherichia coli. Infect. Immun. 18 : 775 - 779 .
12. Scotland , S. M. , H. R. Smith , and B. Rowe . 1985 . Two distinct toxins active on Vero cells from Escherichia coli O157. Lancet . 2 : 885 - 886 .
13. Yutsudo , T. , T. Honda , T. Miwatani , and Y. Takeda . 1986 . Characterization of purified Shiga toxin from Shigella dysenteriae 1. Microbiol. Immunol. 30 : 1115 - 1127 .
14. Lingwood , C. A. , H. Law , S. Richardson , M. Petric , J. L. Brunton , S. de Grandis , and M. Karmali . 1987 . Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. J. Biol. Chem. 262 : 8834 - 8839 .
15. Samuel , J. E. , L. P. Perera , S. Ward , A. D. O'Brien , V. Ginsburg , and H. C. Krivan . 1990 . Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants. Infect. Immun. 58 : 611 - 618 .
16. Armstrong , G. D. , E. Fodor , and R. Vanmaele . 1991 . Investigation of Shiga-like toxin binding to chemically synthesized oligosaccharide sequences. J. Infect. Dis. 164 : 1160 - 1167 .
17. Lindgren , S. W. , J. E. Samuel , C. K. Schmitt , and A. D. O'Brien . 1994 . The specific activities of Shiga-like toxin type II (SLT-II) and SLT-II-related toxins of enterohemorrhagic Escherichia coli differ when measured by Vero cell cytotoxicity but not by mouse lethality. Infect. Immun. 62 : 623 - 631 .
18. Keusch , G. T. , M. Jacewicz , D. W. K. Acheson , A. Donohue-Rolfe , A. V. Kane , and R. H. McCluer . 1995 . Globotriaosylceramide, Gb3, is an alternative functional receptor for Shiga-like toxin 2e. Infect. Immun. 63 : 1138 - 1141 .
19. Khine , A. A. , P. Tam , A. Nutikka , and C. A. Lingwood . 2004 . Brefeldin A and filipin distinguish two globotriaosyl ceramide/ verotoxin-1 intracellular trafficking pathways involved in Vero cell cytotoxicity. Glycobiology . 14 : 701 - 712 .
20. Sekino , T. , N. Kiyokawa , T. Taguchi , H. Takenouchi , J. Matsui , W-R. Tang , T. Suzuki , H. Nakajima , M. Saito , K. Ohmi , et al . 2004 . Characterization of a Shiga-toxin 1-resistant stock of Vero cells. Microbiol. Immunol. 48 : 377 - 387 .
21. Brigotti , M. , A. Caprioli , A. E. Tozzi , P. L. Tazzari , F. Ricci , R. Conte , D. Carnicelli , M. A. Procaccino , F. Minelli , A. V. Ferreti , et al . 2006 . Shiga toxins present in the gut and in the polymorphonuclear leukocytes circulating in the blood of children with hemolytic-uremic syndrome. J. Clin. Microbiol. 44 : 313 - 317 .
22. Gallegos , K. M. , D. G. Conrady , S. S. Karve , T. S. Gunasekera , A. B. Herr , and A. A. Weiss . 2012 . Shiga toxin binding to glycolipids and glycans. PLoS One . 7 : e30368 .
23. Toval , F. , R. Schiller , I. Meisen , J. Putze , I. U. Kouzel , W. Zhang , H. Karch , M. Bielaszewska , M. Mormann , J. Müthing , et al . 2014 . Characterization of urinary tract infection-associated Shiga toxinproducing Escherichia coli. Infect. Immun. 82 : 4631 - 4642 .
24. Tietze , E. , P. W. Dabrowski , R. Prager , A. Radonic , A. Fruth , P. Aura A. Nitsche , M. Mielke , and A. Flieger . 2015 . Comparative genomic analysis of two novel sporadic Shiga toxin-producing Escherichia coli O104:H4 strains isolated 2011 in Germany. PLoS One . 10 : e0122074 .
25. Karmali , M. A. 1989 . Infection by verocytotoxin-producing Escherichia coli. Clin. Microbiol. Rev. 2 : 15 - 38 .
26. Bielaszewska , M. , A. Mellmann , W. Zhang , R. Köck , A. Fruth , A. Bauwens , G. Peters , and H. Karch . 2011 . Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study. Lancet Infect. Dis. 11 : 671 - 676 .
27. Karch , H. , E. Denamur , U. Dobrindt , B. B. Finlay , R. Hengge , L. Johannes , E. Z. Ron , T. Tønjum , P. J. Sansonetti , and M. Vicente . 2012 . The enemy within us: lessons from the 2011 European Escherichia coli O104:H4 outbreak. EMBO Mol. Med. 4 : 841 - 848 .
28. Davis , T. K. , N. C. van de Kar , and P. I. Tarr . 2014 . Shiga toxin/ verocytotoxin-producing Escherichia coli infections: practical clinical perspectives. Microbiol. Spectr. 2 : doi:10.1128/microbiolspec. EHEC-0025-2014.
29. Terajima , J. , S. Iyoda , M. Ohnishi , and H. Watanabe . 2014 . Shiga toxin (verotoxin)-producing Escherichia coli in Japan. Microbiol. Spectr. 2 : doi:10.1128/microbiolspec.EHEC-0011-2013.
30. Motto , D. 2012 . Endothelial cells and thrombotic microangiopathy. Semin. Nephrol. 32 : 208 - 214 .
31. Trachtman , H. , C. Austin , M. Lewinski , and R. A. Stahl . 2012 . Renal and neurological involvement in typical Shiga toxin-associated HUS. Nat. Rev. Nephrol. 8 : 658 - 669 .
32. Bauwens , A. , J. Betz , I. Meisen , B. Kemper , H. Karch , and J. Müthing . 2013 . Facing glycosphingolipid-Shiga toxin interaction: dire straits for endothelial cells of the human vasculature. Cell. Mol. Life Sci. 70 : 425 - 457 .
33. Zoja , C. , S. Buelli , and M. Morigi . 2010 . Shiga toxin-associated hemolytic uremic syndrome: pathophsyiology of endothelial dysfunction. Pediatr. Nephrol. 25 : 2231 - 2240 .
34. Bergan , J. , A. B. Dyve Lingelem , R. Simm , T. Skotland , and K. Sandvig . 2012 . Shiga toxins. Toxicon . 60 : 1085 - 1107 .
35. Sandvig , K. , J. Bergan , S. Kavaliauskiene , and T. Skotland . 2014 . Lipid requirements for entry of protein toxins into cells. Prog. Lipid Res. 54 : 1 - 13 .
36. Johannes , L. , and W. Römer . 2010 . Shiga toxins-from cell biology to biomedical applications. Nat. Rev. Microbiol. 8 : 105 - 116 .
37. Sandvig , K. , J. Bergan , A. B. Dyve , T. Skotland , and M. L. Torgersen . 2010 . Endocytosis and retrograde transport of Shiga toxin. Toxicon . 56 : 1181 - 1185 .
38. Scheutz , F. , L. D. Teel , L. Beutin , D. Piérard , G. Buvens , H. Karch , A. Mellmann , A. Caprioli , R. Tozzoli , S. Morabito , et al . 2012 . Multicenter evaluation of a sequence-based protocol for subtyping Shiga toxins and standardizing Stx nomenclature. J. Clin. Microbiol. 50 : 2951 - 2963 .
39. Müthing , J. , I. Meisen , W. Zhang , M. Bielaszewska , M. Mormann , R. Bauerfeind , M. A. Schmidt , A. W. Friedrich , and H. Karch . 2012 . Promiscuous Shiga toxin 2e and its intimate relationship to Forssman. Glycobiology . 22 : 849 - 862 .
40. Levery , S. B. 2005 . Glycosphingolipid structural analysis and glycosphingolipidomics. Methods Enzymol. 405 : 300 - 369 .
41. Müthing , J. , and U. Distler . 2010 . Advances on the compositional analysis of glycosphingolipids combining thin-layer chromatography with mass spectrometry. Mass Spectrom. Rev. 29 : 425 - 479 .
42. Merrill , A. H. , Jr . 2011 . Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics. Chem. Rev. 111 : 6387 - 6422 .
43. Merrill , A. H. , Jr ., E. M. Schmelz , D. L. Dillehay , S. Spiegel , J. A. Shayman , J. J. Schroeder , R. T. Riley , K. A. Voss , and E. Wang . 1997 . Sphingolipids-the enigmatic lipid class: biochemistry, physiology, and pathophysiology. Toxicol. Appl. Pharmacol. 142 : 208 - 225 .
44. Merrill , A. H. , Jr ., and G. M. Carman . 2015 . Introduction to thematic minireview series: novel bioactive sphingolipids. J. Biol. Chem. 290 : 15362 - 15364 .
45. Yu , R. K. , Y. Nakatani , and M. Yanagisawa . 2009 . The role of glycosphingolipid metabolism in the developing brain. J. Lipid Res. 50 ( Suppl ): S440 - S445 .
46. Yu , R. K. , Y. T. Tsai , and T. Ariga . 2012 . Functional roles of gangliosides in neurodevelopment: an overview of recent advances. Neurochem. Res. 37 : 1230 - 1244 .
47. Schengrund , C. L. 2015 . Gangliosides: glycosphingolipids essential for normal neural development and function. Trends Biochem. Sci. 40 : 397 - 406 .
48. Zheng , W. , J. Kollmeyer , H. Symolon , A. Momin , E. Munter , E. Wang , S. Kelly , J. C. Allegood , Y. Liu , Q. Peng , et al . 2006 . Ceramides and other bioactive sphingolipid backbones in health and disease: lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy. Biochim. Biophys. Acta . 1758 : 1864 - 1884 .
49. Soltwisch , J. , H. Kettling , S. Vens-Cappell , M. Wiegelmann , J. Müthing , and K. Dreisewerd . 2015 . Mass spectrometry imaging with laser-induced postionization. Science . 348 : 211 - 215 .
50. Jennemann , R. , and H. J. Gröne . 2013 . Cell-specific in vivo functions of glycosphingolipids: lessons from genetic deletions of enzymes involved in glycosphingolipid synthesis. Prog. Lipid Res. 52 : 231 - 248 .
51. Furukawa , K. , Y. Ohmi , Y. Kondo , Y. Ohkawa , O. Tajima , and K. Furukawa . 2015 . Regulatory function of glycosphingolipids in the inflammation and degeneration. Arch. Biochem. Biophys. 571 : 58 - 65 .
52. Róg , T. , and I. Vattulainen . 2014 . Cholesterol, sphingolipids, and glycolipids: what do we know about their role in raft-like membranes. Chem. Phys. Lipids . 184 : 82 - 104 .
53. Lingwood , D. , and K. Simons . 2010 . Lipid rafts as a membraneorganizing principle. Science . 327 : 46 - 50 .
54. Simons , K. , and M. J. Gerl . 2010 . Revitalizing membrane rafts: new tools and insights. Nat. Rev. Mol. Cell Biol. 11 : 688 - 699 .
55. Sonnino , S. , and A. Prinetti . 2013 . Membrane domains and the 'lipid raft' concept. Curr. Med. Chem. 20 : 4 - 21 .
56. Lencer , W. I. , and D. Saslowsky . 2005 . Raft trafficking of AB5 subunit bacterial toxins. Biochim. Biophys. Acta . 1746 : 314 - 321 .
57. Aigal , S. , J. Claudinon , and W. Römer . 2015 . Plasma membrane reorganization: a glycolipid gateway for microbes. Biochim. Biophys. Acta . 1853 : 858 - 871 .
58. London , E. , and D. A. Brown . 2000 . Insolubility of lipids in Triton X-100: physical origin and relationship to sphingolipid/cholesterol membrane domains (rafts). Biochim. Biophys. Acta . 1508 : 182 - 195 .
59. Klotzsch , E. , and G. J. Schütz . 2013 . A critical survey of methods to detect plasma membrane rafts. Philos. Trans. R. Soc. Lond. B Biol. Sci. 368 : 20120033 .
60. Lingwood , D. , and K. Simons . 2007 . Detergent resistance as a tool in membrane research. Nat. Protoc. 2 : 2159 - 2165 .
61. Bauwens , A. , M. Bielaszewska , B. Kemper , P. Langehanenberg , G. von Bally , R. Reichelt , D. Mulac , H-U. Humpf , A. W. Friedrich , K. S. Kim , et al . 2011 . Differential cytotoxic actions of Shiga toxin 1 and Shiga toxin 2 on microvascular and macrovascular endothelial cells. Thromb. Haemost. 105 : 515 - 528 .
62. Betz , J. , M. Bielaszewska , A. Thies , H. U. Humpf , K. Dreisewerd , H. Karch , K. S. Kim , A. W. Friedrich , and J. Müthing . 2011 . Shiga toxin glycosphingolipid receptors in microvascular and macrovascular endothelial cells: differential association with membrane lipid raft microdomains. J. Lipid Res. 52 : 618 - 634 .
63. Storck , W. , I. Meisen , K. Gianmoena , I. Pläger , I. U. Kouzel , M. Bielaszewska , J. Haier , M. Mormann , H. U. Humpf , H. Karch , et al . 2012 . Shiga toxin glycosphingolipid receptor expression and toxin susceptibility of human pancreatic ductal adenocarcinomas of differing origin and differentiation. Biol. Chem. 393 : 785 - 799 .
64. Ledeen , R. W. , and R. K. Yu . 1982 . Gangliosides: structure, isolation, and analysis. Methods Enzymol. 83 : 139 - 191 .
65. Müthing , J. , H. Egge , B. Kniep , and P. F. Mühlradt . 1987 . Structural characterization of gangliosides from murine T lymphocytes. Eur. J. Biochem. 163 : 407 - 416 .
66. Meisen , I. , A. W. Friedrich , H. Karch , U. Witting , J. Peter-Kataliní , and J. Müthing . 2005 . Application of combined highperformance thin-layer chromatography immunostaining and nanoelectrospray ionization quadrupole time-of-flight tandem mass spectrometry to the structural characterization of high- and low-affinity binding ligands of Shiga toxin 1. Rapid Commun. Mass Spectrom. 19 : 3659 - 3665 .
67. Souady , J. , J. Soltwisch , K. Dreisewerd , J. Haier , J. Peter-Kataliniæ , and J. Müthing . 2009 . Structural profiling of individual glycosphingolipids in a single thin-layer chromatogram by multiple sequential immunodetection matched with direct IR-MALDI-o-TOF mass spectrometry. Anal. Chem. 81 : 9481 - 9492 .
68. Chester , M. A. 1998 . IUPAC-IUB Joint Commission on Biochemical Nomen clature (JCBN). Nomenclature of glycolipids -recommendations 1997 . Eur. J. Biochem. 257 : 293 - 298 .
69. Meisen , I. , R. Rosenbrück , H. J. Galla , S. Hüwel , I. U. Kouzel , M. Mormann , H. Karch , and J. Müthing . 2013 . Expression of Shiga toxin 2e glycosphingolipid receptors of primary porcine brain endothelial cells and toxin-mediated breakdown of the blood-brain barrier. Glycobiology . 23 : 745 - 759 .
70. Kouzel , I. U. , G. Pohlentz , W. Storck , L. Radamm , P. Hoffmann , M. Bielaszewska , A. Bauwens , C. Cichon , M. A. Schmidt , M. Mormann , et al . 2013 . Association of Shiga toxin glycosphingolipid receptors with membrane microdomains of toxin-sensitive lymphoid and myeloid cells. J. Lipid Res. 54 : 692 - 710 .
71. Kouzel , I. U. , A. Pirkl , G. Pohlentz , J. Soltwisch , K. Dreisewerd , H. Karch , and J. Müthing . 2014 . Progress in detection and structural characterization of glycosphingolipids in crude lipid extracts by enzymatic phospholipid disintegration combined with thin-layer chromatography immunodetection and IR-MALDI mass spectrometry. Anal. Chem. 86 : 1215 - 1222 .
72. Schweppe , C. H. , P. Hoffmann , J-R. Nofer , G. Pohlentz , M. Mormann , H. Karch , A. W. Friedrich , and J. Müthing . 2010 . Neutral glycosphingolipids in human blood: a precise mass spectrometry analysis with special reference to lipoprotein-associated Shiga toxin receptors. J. Lipid Res. 51 : 2282 - 2294 .
73. Dittmer , J. C. , and R. L. Lester . 1964 . A simple, specific spray for the detection of phospholipids on thin-layer chromatograms. J. Lipid Res. 5 : 126 - 127 .
74. Müthing , J. , and M. Radloff . 1998 . Nanogram detection of phospholipids on thin-layer chromatograms. Anal. Biochem. 257 : 67 - 70 .
75. Goswami , S. K. , and C. F. Frey . 1970 . Manganous chloride spray reagent for cholesterol and bile acids on thin-layer chromatograms. J. Chromatogr. 53 : 389 - 390 .
76. Müthing , J. 1998 . TLC in structure and recognition studies of glycosphingolipids. In Methods in Molecular Biology. E. F. Hounsell, editor. Humana Press Inc., Totawa, NJ. 183-195.
77. Müthing , J. , R. Spanbroek , J. Peter-Kataliní , F. G. Hanisch , C. Hanski , A. Hasegawa , F. Unland , J. Lehmann , H. Tschesche , and H. Egge . 1996 . Isolation and structural characterization of fucosylated gangliosides with linear poly-N-acetyllactosaminyl chains from human granulocytes. Glycobiology . 6 : 147 - 156 .
78. Betz , J. , A. Bauwens , L. Kunsmann , M. Bielaszewska , M. Mormann , H. U. Humpf , H. Karch , A. W. Friedrich , and J. Müthing . 2012 . Uncommon membrane distribution of Shiga toxin glycosphingolipid receptors in toxin-sensitive human glomerular microvascular endothelial cells. Biol. Chem. 393 : 133 - 147 .
79. Meisen , I. , J. Peter-Kataliní , and J. Müthing . 2004 . Direct analysis of silica gel extracts from immunostained glycosphingolipids by nanoelectrospray ionization quadrupole time-of-flight mass spectrometry. Anal. Chem. 76 : 2248 - 2255 .
80. Brown , D. A. , and J. K. Rose . 1992 . Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains dueing transport to the apical cell surface. Cell . 68 : 533 - 544 .
81. R Development Core Team . 2010 . R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, http://www.R-project.org .
82. Egge , H. , and J. Peter-Kataliní . 1987 . Fast atom bombardment mass spectrometry for structural elucidation of glycoconjugates. Mass Spectrom. Rev. 6 : 331 - 393 .
83. Pudymaitis , A. , G. Armstrong , and C. A. Lingwood . 1991 . Verotoxin-resistant cell clones are deficient in the glycolipid globotriaosylceramide: differential basis of phenotype. Arch. Biochem. Biophys. 286 : 448 - 452 .
84. Bielaszewska , M. , and H. Karch . 2005 . Consequences of enterohemorrhagic Escherichia coli infection for the vascular endothelium. Thromb. Haemost. 94 : 312 - 318 .
85. Lingwood , C. A. , B. Binnington , A. Manis , and D. R. Branch . 2010 . Globotriaosyl ceramide receptor function - Where membrane structure and pathology intersect. FEBS Lett. 584 : 1879 - 1886 .
86. Blomberg , J. , M. E. Breimer , and K. A. Karlsson . 1982 . Glycosphingolipids of a green monkey kidney cell line (GMK AH-1). Evidence for a novel pentaglycosylceramide based on globotetraosylceramide. Biochim. Biophys. Acta . 711 : 466 - 477 .
87. Sonnino , S. , A. Prinetti , L. Mauri , V. Chigorno , and G. Tettamanti . 2006 . Dynamic and structural properties of sphingolipids as driving forces for the formation of membrane domains. Chem. Rev. 106 : 2111 - 2125 .
88. Gupta , G. , and A. Surolia . 2010 . Glycosphingolipids in microdomain formation and their spatial organization. FEBS Lett. 584 : 1634 - 1641 .
89. Quinn , P. J. 2010 . A lipid matrix model of membrane raft structure. Prog. Lipid Res. 49 : 390 - 406 .
90. Yamashita , T. 2012 . Recent advances in the study of glycosphingolipids. Curr. Pharm. Biotechnol. 13 : 2663 - 2668 .
91. Sonnino , S. , and A. Prinetti . 2010 . Lipids and membrane lateral organization. Front. Physiol. 1 : 153 .
92. Fantini , J. , M. Maresca , D. Hammache , N. Yahi , and O. Delézay . 2000 . Glycosphingolipid (GSL) microdomain as attachment platforms for host pathogens and their toxins on intestinal epithelial cells: activation of signal transduction pathways and perturbations of intestinal absorption and secretion. Glycoconj. J. 17 : 173 - 179 .
93. Vieira , F. S. , G. Corrêa , M. Einicker-Lamast , and R. C. Coutinho-Silva . 2010 . Host-cell lipid rafts: a safe door for micro-organisms? Biol. Cell . 102 : 391 - 407 .
94. Ewers , H. , and A. Helenius . 2011 . Lipid-mediated endocytosis. Cold Spring Harb. Perspect. Biol. 3 : a004721 .
95. Hanashima , T. , M. Miyake , K. Yahiro , Y. Iwamaru , A. Ando , N. Morinaga , and M. Noda . 2008 . Effect of Gb3 in lipid rafts in resistance to Shiga-like toxin of mutant Vero cells. Microb. Pathog. 45 : 124 - 133 .
96. Lingwood , D. , B. Binnington , T. Róg , I. Vattulainen , M. Grzybek , Ü. Coskun , C. A. Lingwood , and K. Simons . 2011 . Cholesterol modulates glycolipid conformation and receptor activity. Nat. Chem. Biol. 7 : 260 - 262 .
97. Mahfoud , R. , A. Manis , B. Binnington , C. Ackerley , and C. A. Lingwood . 2010 . A major fraction of glycosphingolipids in model and cellular cholesterol-containing membranes is undetectable by their binding proteins. J. Biol. Chem. 285 : 36049 - 36059 .
98. Chakraborty , M. , and X. C. Jiang . 2013 . Sphingomyelin and its role in cellular signaling. Adv. Exp. Med. Biol. 991 : 1 - 14 .
99. Cho , J. A. , D. J. Chinnapen , E. Aamar , Y. M. te Welscher , W. I. Lencer , and R. Massol . 2012 . Insights on the trafficking and retrotranslocation of glycosphingolipid-binding bacterial toxins. Front. Cell. Infect. Microbiol. 2 : 51 .
100. Chatterjee , D. , and K. Chaudhuri . 2011 . Association of cholera toxin with Vibrio cholerae outer membrane vesicles which are internalized by human intestinal epithelial cells. FEBS Lett. 585 : 1357 - 1362 .
101. Kunsmann , L. , C. Rüter , A. Bauwens , L. Greune , M. Glüder , B. Kemper , A. Fruth , S. N. Wai , X. He , R. Lloubes , et al . 2015 . Virulence from vesicles: novel mechanisms of host cell injury by Escherichia coli O104:H4 outbreak strain. Sci. Rep. 5 : 13252 .
102. Bielaszewska , M. , T. Aldick , A. Bauwens , and H. Karch . 2014 . Hemolysin of enterohemorrhagic Escherichia coli : structure, transport, biological activity and putative role in virulence. Int. J. Med. Microbiol. 304 : 521 - 529 .